Sponsor Pipeline

Newish Technology (Beijing) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-02 NCT07092007
NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer		 overall status: Recruiting → Unknown
2026-08-02 NCT06741150
NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical…		 overall status: Recruiting → Unknown
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07324304 NWRD06 DNA Plasmid for HCC After Curative Resection. Hepatocellular Carcinoma (HCC) Recruiting
Disease Areas
Liver Cancer (1)
Get alerts when Newish Technology (Beijing) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free